Novabay Pharmaceuticals Inc (NBY)

CUSIP: 66987P409 | NYSE | Healthcare · Biotechnology | Micro Cap | 39 institutional holders

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile

Beneficial Ownership — 13D / 13G

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

Holder	Shares	% of Class	Change	Event Date	vs 13F
13D/AKazley Michael John with R01 Fund LP, R01 Capital Manager LLC, R01 Capital LLC	15,480,044	58.1%	−41,326,036	Mar 31, 2026	No 13F filer matched
13D/AFramework Ventures IV L.P.	56,806,080	45.0%

Institutional Holders — Q1 2026

Sort by

Vanguard Group Inc0

0.0% of portfolio$0

				Style	Turnover	Location	Filed
Vanguard Group Inc	0	$0	0.0%	N/A	N/A	Valley Forge, PA	2026-05-14

13D/AKazley Michael John15,480,044

58.1% of class · Mar 31, 2026−41,326,036

with R01 Fund LP, R01 Capital Manager LLC, R01 Capital LLC

No 13F filer matched

13D/AFramework Ventures IV L.P.56,806,080

45.0% of class · Jan 16, 2026Unchanged

No 13F filer matched

13D/ADavid E. Lazar6,388,000

5.0% of class · Oct 21, 2025+4,885,920

No 13F filer matched

13D/APoplar Point Capital Management LLC1,020,300

0.8% of class · Oct 20, 2025Unchanged

No 13F filer matched

13D/AR01 Capital Manager LLC56,806,080

45.1% of class · Oct 16, 2025+55,641,963

No 13F filer matched

13D/AMichael Ernest Anderson56,806,080

45.1% of class · Oct 16, 2025+55,641,963

No 13F filer matched

13DFramework Ventures IV GP LLC1,164,117

16.2% of class · Oct 9, 2025New 5%+ stake

No 13F filer matched